Hyperthermic intraperitoneal chemotherapy: methodology and safety considerations

Surg Oncol Clin N Am. 2012 Oct;21(4):543-57. doi: 10.1016/j.soc.2012.07.001.

Abstract

Several methods of delivering hyperthermic intraperitoneal chemotherapy (HIPEC) during the course of cytoreductive surgery have been described, but no significant differences in treatment results have been found among them. HIPEC is a safe treatment for the patient and for healthcare workers involved in the procedure provided standard protective and environmental measures are used. This article describes the different techniques in use and the technology available for the administration of HIPEC. Also reviewed are the safety features that must be taken into consideration when performing this procedure. Recommended guidelines to prevent associated occupational hazards are provided.

Publication types

  • Review

MeSH terms

  • Carcinoma / drug therapy*
  • Carcinoma / surgery
  • Chemotherapy, Cancer, Regional Perfusion / adverse effects*
  • Chemotherapy, Cancer, Regional Perfusion / methods
  • Humans
  • Hyperthermia, Induced / methods*
  • Infusions, Parenteral / adverse effects*
  • Infusions, Parenteral / methods
  • Peritoneal Neoplasms / drug therapy*
  • Peritoneal Neoplasms / surgery
  • Safety